Tramadol abuse potential and resultant withdrawal seizures


  • Amitabh Saha Department of Psychiatry, Armed Forces Medical College, Command Hospital, Pune-411040, Maharashtra, India


Central opioid, Abuse potential, Analgesic, Dependence, Tramadol


Tramadol is a centrally acting atypical opioid analgesic with additional serotonin-norepinephrine reuptake-inhibiting effects used to treat moderate to moderately severe pain with propensity for abuse potential. The case of tramadol dependence discussed in this case report developed severe dependence with high doses of tramadol, used as a drug for treating his migraine. The individual learned to self-medicate with the medication. The author further emphasize on the regulation of tramadol prescription.


Duke AN, Bigelow GE, Lanier RK, Strain EC. Discriminative stimulus effects of tramadol in humans. J Pharmacol Exp Ther. 2011;338:255-62.

Knisely JS, Campbell ED, Dawson KS, Schnoll SH. Tramadol post-marketing surveillance in health care professionals. Drug Alcohol Depend. 2002;68:15-22.

Cicero TJ, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH, et al. A post marketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend. 1999;57:7-22.

Jovanovic-Cupic V, Martinovic Z, Nešic N. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol (Phila). 2006;44:143-6.

Lee CR, McTavish D, Sorkin EM. Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs. 1993;46(2):313-40.

Withdrawal syndrome and dependence: tramadol too. Prescrire Int. 2003;12(65):99-100.

Barsotti CE, Mycyk MB, Reyes J. Withdrawal syndrome from tramadol hydrochloride. Am J Emerg Med. 2003;21(1):87-8.

Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokin. 2004;43(13):879-923.